Skip to main content

Serum Albumin

Serum albumin is the most widely used and most prognostic preoperative laboratory marker in the surgical literature — including across reconstructive urology and urogynecology — and simultaneously the most misinterpreted. The American Society for Parenteral and Enteral Nutrition (ASPEN) 2021 position paper states explicitly that albumin (and prealbumin) are markers of inflammation and nutrition risk, not of malnutrition itself.[1] Low albumin remains a robust predictor of surgical morbidity and mortality, but for reasons that have little to do with caloric or protein intake.


Key Cutoffs

  • < 3.5 g/dL — abnormal.
  • < 3.0 g/dL — severe risk (ACS NSQIP / AGS).
  • ≤ 3.3 g/dL — threshold associated with a 36.5% vs 10.4% complication rate in a 200,015-patient plastic / reconstructive-surgery cohort.[2]

Historical Context

Serum albumin was first proposed as a nutritional-assessment parameter in 1977 and rapidly became a standard component of hospital nutrition workup.[1] Prealbumin (transthyretin) later supplanted it as a "preferred" marker on the strength of its shorter half-life (~ 2 days vs ~ 20 days for albumin).[3][1] Two decades of subsequent evidence have overturned this paradigm.

Why Albumin Does Not Reflect Nutritional Status

Albumin is a negative acute-phase protein. Its serum concentration is driven primarily by:

  • Inflammation — Cytokines reprioritize hepatic protein synthesis away from albumin toward positive acute-phase reactants (CRP, fibrinogen). Elevated CRP is the strongest independent predictor of hypoalbuminemia (adjusted OR 10.51 vs 2.87 for nutritional risk).[4]
  • Capillary leak — Inflammation increases vascular permeability, redistributing albumin from intravascular to interstitial space.[1][5]
  • Accelerated catabolism — Albumin half-life shortens during inflammatory states.[5]
  • Other non-nutritional causes — Crystalloid dilution, liver dysfunction, renal / GI losses, and burns all lower albumin independently of nutrition.[6]

Critically, in healthy individuals, serum albumin and prealbumin do not decline until BMI falls below ~ 12 after ≥ 6 weeks of starvation.[7] Both visceral proteins are profoundly insensitive to nutritional intake alone.

What Albumin Does Predict

Low albumin is a robust predictor of adverse clinical outcomes — morbidity, mortality, surgical complications, prolonged hospitalization — but this reflects the severity of the underlying disease and inflammatory burden, not nutritional deficiency per se.[1][4] A prospective study of 2,465 emergency-department patients found that combining albumin, CRP, and NRS-2002 yielded an AUC of 0.82 for 30-day mortality — superior to any single parameter.[4]

ASPEN / ACG Current Position

  • Albumin and prealbumin are not components of any accepted definition of malnutrition — including GLIM criteria and AND/ASPEN consensus.[1]
  • These values should not be used as proxy measures of total body protein or muscle mass.[1]
  • Normalization of visceral proteins may indicate resolution of inflammation and transition to anabolism rather than response to nutritional therapy.[1][8]
  • Malnutrition diagnosis should rely on nutrition-focused physical examination, validated screening tools (NRS-2002, SGA), and clinical history.[3][9]
  • In older adults specifically, use of albumin to detect malnutrition is "extremely unreliable" and should be discouraged, despite remaining in 60% of EU national guidelines.[9]

Appropriate Clinical Use

Albumin retains value as a marker of nutrition risk (i.e., risk of developing malnutrition if support is not provided) and as a prognostic indicator of disease severity.[1] Dynamic changes in albumin during admission — interpreted alongside CRP — can help stratify patients and guide the intensity of nutritional and clinical intervention.[10] Management of hypoalbuminemia should focus on treating the underlying inflammatory driver rather than infusing albumin.[5]


Reconstructive Relevance

Across the reconstructive-surgery literature, preoperative albumin is the single strongest individual predictor of complications:

  • Plastic / reconstructive — 200,015-patient analysis found a stepwise complication gradient from albumin ≥ 4.5 g/dL down to ≤ 3.3 g/dL (10.4% → 36.5%).[2]
  • Free flap reconstruction (head & neck) — Hypoalbuminemia confers ~ 3.4× increased flap failure risk.[11]
  • Major abdominal / pelvic reconstruction (radical cystectomy, urinary diversion) — Hypoalbuminemia is incorporated into multiple risk calculators (NSQIP, frailty + hypoalbuminemia composite).[12]
  • Obesity + hypoalbuminemia — The combination has a compounding effect on wound complications; an obese patient with normal albumin is not equivalent to an obese patient with low albumin.

For elective major reconstruction (urethroplasty, augmentation, gender-affirming, complex prolapse), the practical framework is:

  1. Use albumin as a risk-stratification tool, not a malnutrition diagnosis.
  2. If low, interpret with CRP: low albumin + high CRP = inflammation-driven; low albumin + low CRP = consider true intake deficit.
  3. Diagnose malnutrition independently (NRS-2002, GLIM, SGA, nutrition-focused physical exam) and intervene on that.
  4. When timeline permits, delay elective reconstruction for nutritional optimization in malnourished patients; do not delay for albumin alone if no malnutrition is established and inflammation is the dominant driver.

See Also


References

1. Evans DC, Corkins MR, Malone A, et al. "The Use of Visceral Proteins as Nutrition Markers: An ASPEN Position Paper." Nutrition in Clinical Practice. 2021;36(1):22–28. doi:10.1002/ncp.10588

2. Alfertshofer M, Knoedler S, Broer PN, et al. "From serum to surgery: the significance of albumin in preoperative risk stratification — an analysis of 200,015 plastic surgery patients." Aesthetic Plastic Surgery. 2026. doi:10.1007/s00266-026-05800-8

3. Keller U. "Nutritional Laboratory Markers in Malnutrition." Journal of Clinical Medicine. 2019;8(6):775. doi:10.3390/jcm8060775

4. Eckart A, Struja T, Kutz A, et al. "Relationship of Nutritional Status, Inflammation, and Serum Albumin Levels During Acute Illness: A Prospective Study." The American Journal of Medicine. 2020;133(6):713–722.e7. doi:10.1016/j.amjmed.2019.10.031

5. Soeters PB, Wolfe RR, Shenkin A. "Hypoalbuminemia: Pathogenesis and Clinical Significance." JPEN. Journal of Parenteral and Enteral Nutrition. 2019;43(2):181–193. doi:10.1002/jpen.1451

6. Allison SP, Lobo DN. "The Clinical Significance of Hypoalbuminaemia." Clinical Nutrition. 2024;43(4):909–914. doi:10.1016/j.clnu.2024.02.018

7. Lorden H, Engelken J, Sprang K, et al. "Malnutrition in solid organ transplant patients: A review of the literature." Clinical Transplantation. 2023;37(11):e15138. doi:10.1111/ctr.15138

8. McClave SA, DiBaise JK, Mullin GE, Martindale RG. "ACG Clinical Guideline: Nutrition Therapy in the Adult Hospitalized Patient." The American Journal of Gastroenterology. 2016;111(3):315–334. doi:10.1038/ajg.2016.28

9. Dent E, Wright ORL, Woo J, Hoogendijk EO. "Malnutrition in Older Adults." Lancet. 2023;401(10380):951–966. doi:10.1016/S0140-6736(22)02612-5

10. Li Y, Chen L, Yang X, et al. "Dynamic Association of Serum Albumin Changes With Inflammation, Nutritional Status and Clinical Outcomes: A Secondary Analysis of a Large Prospective Observational Cohort Study." European Journal of Medical Research. 2025;30(1):679. doi:10.1186/s40001-025-02925-5

11. Herzog I, Panchal D, Sikder S, et al. "Malnutrition in head and neck free flap reconstruction as a predictor of adverse outcomes." Annals of Plastic Surgery. 2024;92(4S Suppl 2):S251–S254. doi:10.1097/SAP.0000000000003868

12. Panayi AC, Knoedler L, Matar DY, et al. "The combined risk predictive power of frailty and hypoalbuminemia in free tissue flap reconstruction: a cohort study of 34,571 patients from the NSQIP database." Microsurgery. 2024;44(4):e31156. doi:10.1002/micr.31156